Press
25+ EMERGING MEDICAL TECHNOLOGY CEOS TO PRESENT THEIR OPPORTUNITIES ONLINE NOVEMBER 3, 2010, HOSTED BY LIFE SCIENCE INTELLIGENCE
HUNTINGTON BEACH, Calif. (October 5, 2010)--BUSINESS WIRE--Life Science Intelligence (LSI), a medical technology market research firm, announced today that more than 25 emerging medtech companies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on November 3, 2010 at 11 a.m. Eastern, sponsored by Medical Capital Advisors and MedC.Partners.
“LSI’s Emerging Medical Technologies Spotlight is a travel-free online event, which serves as a convenient forum for medical technology innovators, investors, and dealmakers to connect and collaborate from their desktops,” said Scott Pantel, President of LSI.
The program will feature select companies that are:
- At various stages of development
- Aiming to disrupt several medtech markets
- Seeking partnerships or licensing deals with larger medtech companies
- Seeking investors
- Seeking acquisition
Registered attendees and LSI members—which include the top medtech dealmaking companies and venture capital firms—will have an opportunity to efficiently preview the innovative presenting companies and then selectively network using LSI’s proprietary and confidential online platform.
Attendees to the meeting get online access to:
- CEO Presentations on 25+ Emerging Companies - Complete with 10-15 Minute Audio & Slides
- The Notebook of 25+ Executive Summaries
- In-Depth Content, Including: Development Stage, Competitive Landscape and Positioning, Technological Advantage, Target Markets, Sales Forecasts, Strategic Partnering Opportunities, Financial & Fund Raising Status, Management Team, IP Position, Exit Strategy, Contact Details & More
- The “Live” Event on November 3, 2010 and On-Demand “Replays” for 12 Months Thereafter
- Networking
Companies presenting their opportunities on November 3rd include:
- bioZhena
- Cytonics
- EndoEvolution
- EndoSphere
- Epinex Diagnostics
- Extremity Medical
- Implandata Ophthalmic Products
- Molecular Detection
- Neosthetic
- NivaSonix
- NsGene
- Pepex Biomedical
- Pico-Tesla Magnetic Therapies
- Profound Technologies
- ScienceTomorrow
- Teneo Medical Development
- Valor Medical
- VectraCor
- Vital Access
“LSI's online venue provides CEOs of emerging medical technologies with a secure platform to efficiently share their business development and investment opportunities to a prominent investment and partnering audience,” said Bernadette Silva, Sr. Director of Business Development & Marketing at LSI. Emerging companies with disruptive medical technologies may apply to present for the November 3rd meeting online.
To access this cutting-edge event or for additional details visit www.EMTspotlight.com.
About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the comprehensive Emerging Medical Technologies® database, quarterly Emerging Medical Technologies® online meetings, traditional market reports, deeply segmented and frequently updated Market Agents™, and global custom market research.
Contact:
Life Science Intelligence
Scott Pantel, 1-714-847-3540
scott@LifeScienceIntelligence.com
www.LifeScienceIntelligence.com
